CVE-2023-29712
MEDIUMCVSS 6.1/10EPSS 0.88%
Last modified
CVE-2023-29712 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. Cross Site Scripting vulnerability found in Vade Secure Gateway allows a remote attacker to execute arbitrary code via a crafted payload to the X-Rewrite-URL parameter.. EPSS estimates a 0.88% chance of exploitation in the next 30 days.
Description
Cross Site Scripting vulnerability found in Vade Secure Gateway allows a remote attacker to execute arbitrary code via a crafted payload to the X-Rewrite-URL parameter.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Vadesecure | Secure Gateway | <= 3.0 |
References
- https://labs.yarix.com/2023/05/vade-secure-gateway-multiple-xss-cve-2023-29712-cve-2023-29713-cve-2023-29714/Exploit, Third Party Advisory
- https://labs.yarix.com/2023/05/vade-secure-gateway-multiple-xss-cve-2023-29712-cve-2023-29713-cve-2023-29714/Exploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-29712?
Cross Site Scripting vulnerability found in Vade Secure Gateway allows a remote attacker to execute arbitrary code via a crafted payload to the X-Rewrite-URL parameter.
How severe is CVE-2023-29712?
CVE-2023-29712 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.88% probability of exploitation in the next 30 days.
How do I fix CVE-2023-29712?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-29712?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
